Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Elevated serum cystatin C in severe OSA younger men without complications.

Zhang XB, Lin QC, Deng CS, Chen GP, Cai ZM, Chen H.

Sleep Breath. 2013 Mar;17(1):235-41. doi: 10.1007/s11325-012-0678-2. Epub 2012 Mar 16.

PMID:
22422580
2.

The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea.

Guven SF, Turkkani MH, Ciftci B, Ciftci TU, Erdogan Y.

Sleep Breath. 2012 Mar;16(1):217-21. doi: 10.1007/s11325-011-0492-2. Epub 2011 Feb 18.

PMID:
21331508
3.

C-reactive protein and heart rate recovery in middle-aged men with severe obstructive sleep apnea.

Chien MY, Lee P, Tsai YF, Yang PC, Wu YT.

Sleep Breath. 2012 Sep;16(3):629-37. doi: 10.1007/s11325-011-0549-2. Epub 2011 Jun 27.

PMID:
21706288
4.

New index for analysis of polysomnography, 'integrated area of desaturation', is associated with high cardiovascular risk in patients with mild to moderate obstructive sleep apnea.

Asano K, Takata Y, Usui Y, Shiina K, Hashimura Y, Kato K, Saruhara H, Yamashina A.

Respiration. 2009;78(3):278-84. doi: 10.1159/000202980. Epub 2009 Feb 16.

PMID:
19218786
5.

[Severe obstructive sleep apnea-hypopnea syndrome with latent renal dysfunction: analysis of 238 cases].

Jiang Q, Li TP, Pang B, Wang X, Wang YF.

Nan Fang Yi Ke Da Xue Xue Bao. 2016 Mar;36(3):339-44. Chinese.

PMID:
27063159
6.

Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi.

Sharma SK, Mishra HK, Sharma H, Goel A, Sreenivas V, Gulati V, Tahir M.

Sleep Med. 2008 Jan;9(2):149-56. Epub 2007 Jul 16.

PMID:
17638590
7.

Effect of continuous positive airway pressure on serum cystatin C among obstructive sleep apnea syndrome patients.

Zhang XB, Jiang XT, Lin QC, Chen X, Zeng HQ.

Int Urol Nephrol. 2014 Oct;46(10):1997-2002. doi: 10.1007/s11255-014-0779-x. Epub 2014 Jul 8.

PMID:
25000895
8.

Mean platelet volume is increased in patients with severe obstructive sleep apnea.

Varol E, Ozturk O, Gonca T, Has M, Ozaydin M, Erdogan D, Akkaya A.

Scand J Clin Lab Invest. 2010 Nov;70(7):497-502. doi: 10.3109/00365513.2010.520733. Epub 2010 Sep 20.

PMID:
20849358
9.

Severe obstructive sleep apnea increases cystatin C in clinically latent renal dysfunction.

Kato K, Takata Y, Usui Y, Shiina K, Asano K, Hashimura Y, Saruhara H, Nishihata Y, Tomiyama H, Yamashina A.

Respir Med. 2011 Apr;105(4):643-9. doi: 10.1016/j.rmed.2010.11.024. Epub 2010 Dec 22.

10.

Increased cardiac troponin T and C-reactive protein levels in end-stage renal disease are associated with obstructive sleep apnea.

Koehnlein T, Schmidt A, Moesenthin M, Dierkes J, Neumann KH, Welte T.

Clin Nephrol. 2009 Jan;71(1):50-8.

PMID:
19203550
11.

Structural and serum surrogate markers of cerebrovascular disease in obstructive sleep apnea (OSA): association of mild OSA with early atherosclerosis.

Saletu M, Nosiska D, Kapfhammer G, Lalouschek W, Saletu B, Benesch T, Zeitlhofer J.

J Neurol. 2006 Jun;253(6):746-52. Epub 2006 Mar 6.

PMID:
16511651
12.
13.

Levels of neuroglobin in serum and neurocognitive impairments in Chinese patients with obstructive sleep apnea.

Xu M, Yang Y, Zhang J.

Sleep Breath. 2013 May;17(2):573-82. doi: 10.1007/s11325-012-0723-1. Epub 2012 Jun 7.

PMID:
22674396
14.

Effects of obstructive sleep apnea severity on serum lipid levels in Greek children with snoring.

Alexopoulos EI, Gletsou E, Kostadima E, Kaditis D, Zakynthinos E, Gourgoulianis K, Kaditis A.

Sleep Breath. 2011 Dec;15(4):625-31. doi: 10.1007/s11325-010-0410-z. Epub 2010 Sep 18.

PMID:
21063795
15.

C-reactive protein in children with obstructive sleep apnea and the effects of treatment.

Li AM, Chan MH, Yin J, So HK, Ng SK, Chan IH, Lam CW, Wing YK, Ng PC.

Pediatr Pulmonol. 2008 Jan;43(1):34-40.

PMID:
18041751
16.

Cystatin C as a marker of glomerular filtration rate in voluntary kidney donors.

Jaisuresh K, Sharma RK, Mehrothra S, Kaul A, Badauria DS, Gupta A, Prasad N, Jain A.

Exp Clin Transplant. 2012 Feb;10(1):14-7.

17.

[Metabolic abnormalities in obstructive sleep apnea patients].

Czerniawska J, Bieleń P, Pływaczewski R, Czystowska M, Korzybski D, Sliwiński P, Górecka D.

Pneumonol Alergol Pol. 2008;76(5):340-7. Polish.

18.

Salivary and serum myeloperoxidase in obstructive sleep apnea.

Akpinar ME, Yigit O, Altundag A, Demirel GY, Kocak I.

J Otolaryngol Head Neck Surg. 2012 Jun 1;41(3):215-21.

PMID:
22762704
19.

Effects of obstructive sleep apnea and its treatment on cardiovascular risk in CAD patients.

Zhao Q, Liu ZH, Zhao ZH, Luo Q, McEvoy RD, Zhang HL, Wang Y.

Respir Med. 2011 Oct;105(10):1557-64. doi: 10.1016/j.rmed.2011.05.010. Epub 2011 Jun 8.

20.

Obstructive sleep apnea and biomarkers of inflammation in ischemic stroke.

Medeiros CA, de Bruin VM, Andrade GM, Coutinho WM, de Castro-Silva C, de Bruin PF.

Acta Neurol Scand. 2012 Jul;126(1):17-22. doi: 10.1111/j.1600-0404.2011.01589.x. Epub 2011 Sep 14.

PMID:
21916851
Items per page

Supplemental Content

Write to the Help Desk